BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 716905)

  • 21. Melanoma case survival rates in South Australia by histological type, thickness and level of tumour at diagnosis.
    Bonett A; Roder D; Esterman A
    Med J Aust; 1986 Jun; 144(13):680-2. PubMed ID: 3724597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant melanoma in Taiwan: a prognostic study of 181 cases.
    Chang JW; Yeh KY; Wang CH; Yang TS; Chiang HF; Wei FC; Kuo TT; Yang CH
    Melanoma Res; 2004 Dec; 14(6):537-41. PubMed ID: 15577327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological type and biological behavior of primary cutaneous malignant melanoma. 2. An analysis of 86 cases located on so-called acral regions as plantar, palmar, and sub-/parungual areas.
    Søndergaard K
    Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):333-43. PubMed ID: 6415910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention and early diagnosis of malignant melanoma].
    Selvåg E; Loeb M; Larsen TE; Thune P
    Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2316-8. PubMed ID: 9691797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malignant melanoma in El Salvador. Study of 101 cases].
    Hernández-Pérez E; Baños JE; Serpas de López RM
    Med Cutan Ibero Lat Am; 1982; 10(4):217-24. PubMed ID: 6763654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant melanoma in the elderly.
    Cohen HJ; Cox E; Manton K; Woodbury M
    J Clin Oncol; 1987 Jan; 5(1):100-6. PubMed ID: 3806154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological and histopathological profile of cutaneous melanoma at a center in northeastern Brazil from 2000 to 2010.
    Vilanova CM; Lages RB; Ribeiro SM; Almeida IP; Santos LG; Vieira SC
    An Bras Dermatol; 2013; 88(4):545-53. PubMed ID: 24068125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Melanoma Res; 2005 Feb; 15(1):73-5. PubMed ID: 15714124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
    Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
    Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Malignant melanoma in Puerto Rico].
    Vázquez-Botet M; Latoni D; Sánchez JL
    Bol Asoc Med P R; 1990 Oct; 82(10):454-7. PubMed ID: 2080958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
    Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
    Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective multicenter evaluation of cutaneous melanomas in Turkey.
    Gamsizkan M; Yilmaz I; Buyukbabani N; Demirkesen C; Demiriz M; Cetin ED; Ince U; Akalin T; Demirkan NC; Lebe B; Erdem O; Gokoz O; Sakiz D; Demireli PT; Astarci HM; Adim SB; Zemheri IE; Acikalin A; Yaman B; Aydin O; Bassorgun CI
    Asian Pac J Cancer Prev; 2014; 15(23):10451-6. PubMed ID: 25556491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant melanoma: basic approach to clinicopathologic correlation.
    Su WP
    Mayo Clin Proc; 1997 Mar; 72(3):267-72. PubMed ID: 9070204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nature of melanoma. A critical review.
    McGovern VJ
    J Cutan Pathol; 1982 Apr; 9(2):61-81. PubMed ID: 7047599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updated statistical data for malignant melanoma in Japan.
    Ishihara K; Saida T; Yamamoto A;
    Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous malignant melanoma: experience of the British Columbia Cancer Agency from 1972 to 1981.
    Carmichael VE; Wilson KS
    Can J Surg; 1992 Dec; 35(6):589-97. PubMed ID: 1458384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An epidemiological study of the distinct histological types of cutaneous melanoma in relation to other variables of the disease].
    Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Agudo Ferrándiz J; Segarra Castelló L
    Rev Clin Esp; 1992 Mar; 190(4):169-76. PubMed ID: 1589611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
    Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
    Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.